Epistaxis in Children: IAP Guidelines

Written By : Ayesha Sadaf |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-08-29T10:15:56+05:30 | Updated On 29 Aug 2022 1:40 PM IST

Epistaxis is defined as bleeding from the nostril, nasal cavity, or nasopharynx that is sufficient to warrant medical advice or care. This includes bleeding that is severe, persistent, and/or recurrent, as well as bleeding that affects a patient's quality of life.

The Indian Academy of Pediatrics (IAP) has released Standard Treatment Guidelines 2022 for Epistaxis in Children. The lead author for these guidelines on Epistaxis in Children is Dr. Shalu Gupta along with co-author Dr. Arpita Gogoi Borgohain and Dr. Swathy Rao. The guidelines come Under the Auspices of the IAP Action Plan 2022, and the members of the IAP Standard Treatment Guidelines Committee include Chairperson Remesh Kumar R, IAP Coordinator Vineet Saxena, National Coordinators SS Kamath, Vinod H Ratageri, Member Secretaries Krishna Mohan R, Vishnu Mohan PT and Members Santanu Deb, Surender Singh Bisht, Prashant Kariya, Narmada Ashok, Pawan Kalyan.

Following are the major recommendations of guidelines:

Epistaxis is a common, usually benign condition of childhood and accounts for about 0.5% of all emergency department visits. Children with epistaxis mainly present between 2 and 10 years of age. About 30% of children aged 2–5 years, 56% of children aged 6–10 years, and 64% of children aged 11–15 years developing epistaxis during their lifetime.

Since epistaxis is so common, how extensive would be the workup and treatment of a child with nasal bleeding can be a difficult decision. While there is no consensus on the duration or frequency of episodes constituting recurrent epistaxis, some studies have defined recurrent epistaxis as five or more episodes per year.

Pathophysiology:

There are diverse causes and risk factors, which can lead to epistaxis. Sometimes the etiology is not clear and thus primary (i.e., idiopathic) epistaxis is the main cause.

Dry atmospheric conditions lacking humidification leads to dried nasal mucosa and associated fissuring of nasal mucosa, subsequently leading to desiccation and exposure of blood vessels.

Mostly, the site of the bleeding is on the anterior nasal septum due to network of small blood vessels known as Kiesselbach's plexus

These vessels are located in a superficial portion of the septal mucosa, which makes them prone to injury from the slightest mechanical or chemical insult. Other sites of bleeding include the lateral nasal wall, particularly the branches of the sphenopalatine artery. Posteriorly, bleeding can arise from posterior branches of the sphenopalatine artery, Woodruff plexus, and venous sources.

Risk Factors and Etiology:

Local inflammation

Prior upper respiratory tract infections

Mucosal drying

Local trauma (including nose picking)

Other specific local (e.g., tumors) or systemic (e.g., clotting disorders) factors.

Primary epistaxis is defined as idiopathic bleeds without identifiable and precipitating factors, whereas bleeds known to be associated with a clear and definitive cause are classified as secondary epistaxis.

The etiology varies in different age groups:

>2 years: Mainly due to local factors

<2 years: Epistaxis is rare (1 per 10,000), must be worked up for:

• Trauma (intentional or unintentional)

• Hematological illness (e.g., thrombocytopenia and clotting disorders)

• Child abuse.

Assessment:

A child presenting with epistaxis should be immediately evaluated for airway obstruction and circulatory imbalance due to the bleed. Initial stabilization is a must before proceeding for the detailed evaluation.

A thorough head and neck examination is important in evaluating any patient with epistaxis. Anterior rhinoscopy should be performed using an otoscope.

If there is a history of trauma, neurologic status and associated blood loss from other sites should be actively looked.

Although epistaxis is usually self-limited, it can be potentially life-threatening.

If the bleeding has been recurrent or prolonged and there has been a significant blood loss, urgent blood group and cross matching, clotting studies, and a full blood count to monitor hemoglobin levels should be done. Once stabilized, a detailed history should be elicited including history of present illness, medical history, and family history.

History of Present Illness:

Age and gender

Rhinorrhea/upper respiratory tract infection

Onset and duration of the bleed

Frequency of the nosebleeds

Nasal laterality of the bleeds

Estimated blood loss

Associated trauma; foreign body; nasal obstruction and discharge; and pain

History of allergic rhinitis

History of nasal and/or paranasal surgery, benign or malignant tumor

Deviated nasal septum.

Past Medical History:

Medications: Antithrombotic agent use (i.e., aspirin, warfarin, etc.)

Past medical history (hypertension and hematologic disease)

Previous nosebleeds requiring emergency or surgical interventions

Underlying chronic illness (i.e., chronic sinusitis, etc.)

Allergies

Easy or unusual bruising or bleeding from other sites (e.g., gingival, menorrhagia, or hemorrhage after dental extraction)

Hematemesis; hematochezia; and melena.

Family History:

Bleeding disorders

Relatives with unusual bleeding tendencies

Use of recreational drugs.

Medical Examination:

At the emergency room/outpatient department, immediate examination of the vitals and general condition of the child has to be done.

Vitals and General Examination

Vitals: Peripheral and central pulses, tachycardia, and hypertension/hypotension

Facial swelling and injuries

Cervical lymphadenopathy (may be associated with malignancies)

Skin: Jaundice, petechiae, ecchymoses, purpura, telangiectasias, and pallor.

Systemic Examination

Central nervous system examination: Glasgow Coma Scale, neurological deficits, and vision or hearing changes [may be associated with juvenile nasopharyngeal angiofibroma (JNA)]

Abdomen: Hepatosplenomegaly (may be associated with malignancies and liver disease)

Cardiovascular system: Murmurs and signs of congestive cardiac failure

Examination of the Nose and Oral Cavity:

Inspection and palpation: Possible external findings

Erythema, abrasion, discharge, or bleeding at the anterior nares

Foul odor and discharge from the nose, often unilateral (may be associated with a foreign body)

Transverse skin crease over the bridge of the nose (seen in persons with allergic rhinitis)

Atopic pleats or Dennie–Morgan folds below the eyes (seen in persons with allergic rhinitis)

Inspection and palpation with a light source (usually an otoscope with a widetipped nasal speculum): Possible internal findings

Vestibulitis (crusting, erythema, and swelling of the nasal vestibule)

Pronounced vessels or obvious bleeding at the anterior septum

Boggy turbinates

Nasal obstruction, masses, polyps, and septal perforation

Sinus tenderness with palpation

Palatal masses (may be seen with angiofibromas)

Telangiectasia of the mouth or lips

Blood in the posterior pharynx and not the nose (may be seen with posterior bleeds).

Medical Examination:

Bleeding Point Identification

The child should be examined for visible bleeding points with a nasal speculum, such as Kiesselbach's plexus (Little's area) and cotton must be placed into the posterior nasal cavity to prevent blood from running down the pharynx.

If a bleeding point could not be identified, the patient should be referred to an otolaryngologist for detailed examination using a flexible/rigid endoscope. Since the blood flows from top to bottom when the patient is seated, the search for a bleeding point with an endoscope should be performed in the following order: upper olfactory cleft, upper middle meatus, lower olfactory cleft, lower middle meatus, common meatus, and inferior meatus.

Treatment:

Management of most nosebleeds primarily revolves around educating the parent and patient on treatment at the time of the bleed as well as using ways to prevent bleeding in the future. The various modalities of treatment include:

Nasal care:

• Patients should be instructed to place constant pressure on the anterior septum by pinching the caudal (soft) portion of the nose with the fingers for 5–10 minutes and should sit straight up or lean slightly forward.

• A common pitfall is holding pressure on the bridge of the nose, which does not provide adequate pressure.

• Blood clots are a source of fibrinolytic enzymes, so if bleeding persists after 5–10 minutes, the nose should be gently blown to evacuate any clots.

• A vasoconstrictor such as oxymetazoline can be sprayed up the nose and pressure reapplied.

Nasal packing: • If bleeding is not controlled after applying adequate pressure or the patient has a frequent or severe recent history of epistaxis, the next step involves doing nasal packing. A rolled-up piece of an absorbable hemostatic agent up against the nasal septum

• These are usually left in for 24–48 hours.

• When not controlled with anterior packing, a posterior bleed should be suspected and an otolaryngologist should be consulted.

Coagulation:

• After applying firm pressure, if bleeding has stopped or slowed sufficiently, an attempt should be made to identify prominent or bleeding vasculature on the anterior nasal septum, which can be easily cauterized with topical silver nitrate.

• Remember use of silver nitrate cautery on both sides of the nasal septum in the same location can cause septal perforation and should be avoided.

• In the acute setting, optimum treatment would be localization and cauterization of the bleeding area.

Endovascular occlusion/embolization:

• It is used in controlling uncontrolled bleeding by occluding the feeding vessels; this significantly reduces the blood supply of the nose and the paranasal sinuses where the epistaxis is originating.

• This should be used in patients with sinonasal tumors and especially preoperative optimization of select vascular tumors.

• However, one must consider side effects such as radiation exposure, limited availability, and increased costs.

• Embolization of the ethmoidal arteries is contraindicated because these are derived from the ophthalmic artery and occlusion can cause blindness.

Minimal invasive surgery:

• Patients with significant and brisk bleeding or unremitting bleed and the patient with signs of airway compromise or hypovolemia would require surgical intervention.

• With improvement in endoscopic technologies, minimally invasive transnasal control of epistaxis has been increasingly performed and is now considered regularly in severe and recurrent epistaxis.

• Transnasal endoscopic sphenopalatine artery ligation (TESPAL) is routinely performed and epistaxis due to other sources (e.g., ethmoidal arteries) can also be endoscopically addressed.

• These procedures do not involve any external incisions, can be done on an outpatient basis, and are less painful.

• Novel interventions including propranolol, potassium titanyl phosphate laser therapy, bilateral nasal cautery, and microwave ablation have shown promise, but more research is needed on their long-term effectiveness and safety.

Reference:

Burton MJ, Dorée CJ. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev. 2004;1:CD004461.
ElAlfy MS, Tantawy A, Eldin BEMB, Mekawy MA, elAziz Mohammad YA, Ebeid FSE. Epistaxis in a pediatric outpatient clinic: could it be an alarming sign? Int Arch Otorhinolaryngol. 2022;26(02): e183-90.
Kucik CJ, Clenney T. Management of epistaxis. Am Fam Physician. 2005;71(2):305.
Send T, Bertlich M, Eichhorn KW, Ganschow R, Schafigh D, Horlbeck F, et al. Etiology, management, and outcome of pediatric epistaxis. Pediatr Emer Care. 2019;37:466-70.
Svider P, Arianpour K, Mutchnick S. Management of Epistaxis in children and adolescents avoiding a chaotic approach. Pediatr Clin N Am. 2018;65:607-21.
Tunkel DE, Anne S, Payne SC, Ishman SL, Rosenfeld RM, Abramson PJ, et al. Clinical practice guideline: nosebleed (Epistaxis). Otolaryngol Head Neck Surg. 2020;162(1S):S1-S38.

The guidelines can be accessed on the official site of IAP: https://iapindia.org/standard-treatment-guidelines/

Indian Academy of PediatricIAP GuidelinesEpistaxisnasopharynxbleedingnostrilsphenopalatine arteryrhinoscopy

Source : Indian Academy of Pediatric, IAP Guidelines

Ayesha Sadaf

I have done my Bachelor of pharmacy from United Institute of Pharmacy and currently pursuing pharmaceutical MBA from Jamia hamdard. I worked as an intern at the position of content creator in Medical Dialogue and am highly obliged to the company for giving me this wonderful opportunity.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751